| Primary |
| Drug Use For Unknown Indication |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
| Blood Pressure Systolic Increased |
50.0% |
| Hypotension |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
20.2% |
| Pulmonary Hypertension |
6.1% |
| Mean Arterial Pressure |
4.6% |
| Anaesthesia |
4.3% |
| Hypertension |
4.3% |
| Prophylaxis |
3.5% |
| Sedation |
3.5% |
| Pain |
3.2% |
| Anxiety |
2.6% |
| Ascites |
2.3% |
| Leukocytosis |
2.3% |
| Pneumoperitoneum |
2.3% |
| Hypotension |
1.7% |
| Multiple Myeloma |
1.7% |
| Perforated Ulcer |
1.7% |
| Pneumonia Aspiration |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Cardiogenic Shock |
1.4% |
| Infection |
1.4% |
|
| Toxic Epidermal Necrolysis |
23.9% |
| Death |
8.7% |
| Respiratory Failure |
8.7% |
| Thrombocytopenia |
6.5% |
| Tricuspid Valve Incompetence |
6.5% |
| White Blood Cell Count Increased |
6.5% |
| Pericarditis |
4.3% |
| Rash |
4.3% |
| Restlessness |
4.3% |
| Sepsis |
4.3% |
| Arteriospasm Coronary |
2.2% |
| Blood Pressure Decreased |
2.2% |
| Bradycardia |
2.2% |
| Cardiac Failure |
2.2% |
| Haemorrhagic Ascites |
2.2% |
| Hyperthermia |
2.2% |
| Mouth Haemorrhage |
2.2% |
| Phaeochromocytoma |
2.2% |
| Pleural Effusion |
2.2% |
| Pneumonia |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.3% |
| Sedation |
9.9% |
| Product Used For Unknown Indication |
8.4% |
| Sepsis |
8.2% |
| Prophylaxis |
6.4% |
| Septic Shock |
4.9% |
| Infection |
3.4% |
| Anaesthesia |
3.3% |
| Analgesic Therapy |
3.3% |
| Hypotension |
3.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.2% |
| Cardiac Failure |
2.9% |
| Pneumonia |
2.9% |
| Anticoagulant Therapy |
2.8% |
| Unevaluable Event |
2.6% |
| Antibiotic Prophylaxis |
2.4% |
| Haemodynamic Instability |
2.4% |
| Acute Myocardial Infarction |
2.3% |
| Hypovolaemia |
2.2% |
| Shock |
2.0% |
|
| Thrombocytopenia |
13.1% |
| Sepsis |
11.7% |
| Septic Shock |
9.0% |
| White Blood Cell Count Increased |
6.6% |
| Renal Failure Acute |
6.2% |
| Multi-organ Failure |
5.2% |
| Renal Failure |
4.8% |
| Death |
4.5% |
| Overdose |
4.1% |
| Bradycardia |
3.8% |
| Vomiting |
3.8% |
| Hypotension |
3.4% |
| Shock Haemorrhagic |
3.4% |
| Ventricular Tachycardia |
3.4% |
| General Physical Health Deterioration |
3.1% |
| Loss Of Consciousness |
3.1% |
| Cardiac Arrest |
2.8% |
| Rectal Haemorrhage |
2.8% |
| Wound Infection |
2.8% |
| Toxic Epidermal Necrolysis |
2.4% |
|
